![Mathias Kroll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathias Kroll
Corporate Officer/Principal at
CYNATA THERAPEUTICS LIMITED
Net worth: - $ as of 2026-05-30
Profile
Mathias Kroll is currently the Director at Abarceo AB and the Chief Business Officer at Cynata Therapeutics Ltd. He previously worked as the Chief Commercial Officer at QIMR Berghofer Medical Research Institute.
He holds an MBA from the International Institute for Management Development and a doctorate from the Pasteur Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-29 | 0 ( -.--% ) | - $ | 2026-05-30 |
Mathias Kroll active positions
| Companies | Position | Start |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Corporate Officer/Principal | 2024-03-31 |
Abarceo AB
 Abarceo AB Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for type-2 diabetes | Director/Board Member | - |
Former positions of Mathias Kroll
| Companies | Position | End |
|---|---|---|
QIMR Berghofer Medical Research Institute
 QIMR Berghofer Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as medical research institute | Corporate Officer/Principal | - |
Training of Mathias Kroll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
QIMR Berghofer Medical Research Institute
QIMR Berghofer Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as medical research institute | Commercial Services |
Abarceo AB
Abarceo AB Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics for type-2 diabetes | Commercial Services |
Pasteur Institute
 Pasteur Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Mathias Kroll
